Johnson & Johnson is reportedly on track to meet its vaccine distribution goal; FDA grants emergency use authorization to Amazon for an at-home COVID-19 test; 6 states expand vaccine eligibility to all adults, with 3 more states to follow later this week.
Reported by POLITICO, the Biden administration said last Friday that Johnson & Johnson (J&J) is on track to meet its distribution goal of 20 million doses of its COVID-19 vaccine by month’s end after reports that it could potentially miss its vaccine delivery deadline. Having sent 4 million of the 20 million doses to states and federal partners, White House coronavirus response coordinator Jeff Zients said the company is due to send the government 11 million more doses this week, with expectations of a significant increase in doses by the end of March to meet its goal.
The FDA granted emergency use authorization (EUA) to Amazon for an at-home nasal swab and PCR-based test for COVID-19, according to STAT. Called the Amazon COVID-19 Collection Kit, the test would allow users to self-test without supervision of a health care professional. The move adds to Amazon’s foray into health care, with its virtual-first health care platform, Amazon Care, announced to be made available to all its workers and to interested private employers by this summer.
Today, 6 states—Kansas, Louisiana, North Dakota, Ohio, Oklahoma, and Texas—are expanding eligibility for the COVID-19 vaccine to all adults, with Minnesota, Indiana, and South Carolina to follow later this week. As reported by The New York Times, cases of COVID-19 have risen significantly over the past week, with approximately 15,000 more cases this past Friday compared with the Friday before. Nearly all states have pledged to expand vaccine eligibility to all adults by May 1; Northeastern states accounted for about 30% of new US cases in the past 2 weeks.
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Alzheimer Disease and Related Dementias Cause Surging Economic Burden for Minoritized Communities
June 5th 2025African American and Latino older adults with Alzheimer disease and related dementias and their families are likely to face disproportionately high burdens, primarily associated with unpaid caregiving, suggesting the need for policies that may reduce economic burdens for all US residents.
Read More
Use of Voluntary Alignment in the Next Generation ACO Model
June 5th 2025Use of voluntary alignment attribution by Next Generation Accountable Care Organization (ACO) participants was limited. The authors highlight the reasons and describe organizational use cases via a mixed-methods approach.
Read More